India to set regulatory provisions for devices
This article was originally published in Clinica
Executive Summary
The Indian government will undertake a number of initiatives to counteract industry concerns that devices are not sufficiently distinguished from drugs under current regulations. Its announcement follows the approval of an autonomous Central Drugs Authority of India (CDA), and includes proposals for this new authority, whose regulatory responsibilities will extend to medical devices.